Amazon Up, Walgreens, Nike & McPlant Down
Motley Fool Money
The Disruption Dilemma: Weight Loss Drugs and Sleep Apnea Treatments
This chapter explores the effects of weight loss drugs like Eli Lilly's ZepBound on the medical technology sector, especially regarding sleep apnea treatments. It highlights the market fluctuation for ResMed and raises questions about the future of GLP-1 drugs in healthcare.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
